In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.
LPI (LP Information)' newest research report, the “IVD Antibodies Industry Forecast” looks at past sales and reviews total world IVD Antibodies sales in 2022, providing a comprehensive analysis by region and market sector of projected IVD Antibodies sales for 2023 through 2029. With IVD Antibodies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVD Antibodies industry.
This Insight Report provides a comprehensive analysis of the global IVD Antibodies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IVD Antibodies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IVD Antibodies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVD Antibodies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVD Antibodies.
The global IVD Antibodies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for IVD Antibodies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for IVD Antibodies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for IVD Antibodies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key IVD Antibodies players cover Abcam, Thermo Fisher Scientific, Rockland Immunochemicals, GenScript, Bio-Rad Laboratories, SDIX, MEDICAL & BIOLOGICAL LABORATORIES, HyTest and Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of IVD Antibodies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cardiac Markers
Tumor Markers
Kidney Injury Markers
Segmentation by application
Hospital
Specialty Clinic
Diagnostic Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abcam
Thermo Fisher Scientific
Rockland Immunochemicals
GenScript
Bio-Rad Laboratories
SDIX
MEDICAL & BIOLOGICAL LABORATORIES
HyTest
Abbott

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global IVD Antibodies Market Size 2018-2029 2.1.2 IVD Antibodies Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 IVD Antibodies Segment by Type 2.2.1 Cardiac Markers 2.2.2 Tumor Markers 2.2.3 Kidney Injury Markers 2.3 IVD Antibodies Market Size by Type 2.3.1 IVD Antibodies Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global IVD Antibodies Market Size Market Share by Type (2018-2023) 2.4 IVD Antibodies Segment by Application 2.4.1 Hospital 2.4.2 Specialty Clinic 2.4.3 Diagnostic Center 2.4.4 Others 2.5 IVD Antibodies Market Size by Application 2.5.1 IVD Antibodies Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global IVD Antibodies Market Size Market Share by Application (2018-2023) 3 IVD Antibodies Market Size by Player 3.1 IVD Antibodies Market Size Market Share by Players 3.1.1 Global IVD Antibodies Revenue by Players (2018-2023) 3.1.2 Global IVD Antibodies Revenue Market Share by Players (2018-2023) 3.2 Global IVD Antibodies Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 IVD Antibodies by Regions 4.1 IVD Antibodies Market Size by Regions (2018-2023) 4.2 Americas IVD Antibodies Market Size Growth (2018-2023) 4.3 APAC IVD Antibodies Market Size Growth (2018-2023) 4.4 Europe IVD Antibodies Market Size Growth (2018-2023) 4.5 Middle East & Africa IVD Antibodies Market Size Growth (2018-2023) 5 Americas 5.1 Americas IVD Antibodies Market Size by Country (2018-2023) 5.2 Americas IVD Antibodies Market Size by Type (2018-2023) 5.3 Americas IVD Antibodies Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC IVD Antibodies Market Size by Region (2018-2023) 6.2 APAC IVD Antibodies Market Size by Type (2018-2023) 6.3 APAC IVD Antibodies Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe IVD Antibodies by Country (2018-2023) 7.2 Europe IVD Antibodies Market Size by Type (2018-2023) 7.3 Europe IVD Antibodies Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa IVD Antibodies by Region (2018-2023) 8.2 Middle East & Africa IVD Antibodies Market Size by Type (2018-2023) 8.3 Middle East & Africa IVD Antibodies Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global IVD Antibodies Market Forecast 10.1 Global IVD Antibodies Forecast by Regions (2024-2029) 10.1.1 Global IVD Antibodies Forecast by Regions (2024-2029) 10.1.2 Americas IVD Antibodies Forecast 10.1.3 APAC IVD Antibodies Forecast 10.1.4 Europe IVD Antibodies Forecast 10.1.5 Middle East & Africa IVD Antibodies Forecast 10.2 Americas IVD Antibodies Forecast by Country (2024-2029) 10.2.1 United States IVD Antibodies Market Forecast 10.2.2 Canada IVD Antibodies Market Forecast 10.2.3 Mexico IVD Antibodies Market Forecast 10.2.4 Brazil IVD Antibodies Market Forecast 10.3 APAC IVD Antibodies Forecast by Region (2024-2029) 10.3.1 China IVD Antibodies Market Forecast 10.3.2 Japan IVD Antibodies Market Forecast 10.3.3 Korea IVD Antibodies Market Forecast 10.3.4 Southeast Asia IVD Antibodies Market Forecast 10.3.5 India IVD Antibodies Market Forecast 10.3.6 Australia IVD Antibodies Market Forecast 10.4 Europe IVD Antibodies Forecast by Country (2024-2029) 10.4.1 Germany IVD Antibodies Market Forecast 10.4.2 France IVD Antibodies Market Forecast 10.4.3 UK IVD Antibodies Market Forecast 10.4.4 Italy IVD Antibodies Market Forecast 10.4.5 Russia IVD Antibodies Market Forecast 10.5 Middle East & Africa IVD Antibodies Forecast by Region (2024-2029) 10.5.1 Egypt IVD Antibodies Market Forecast 10.5.2 South Africa IVD Antibodies Market Forecast 10.5.3 Israel IVD Antibodies Market Forecast 10.5.4 Turkey IVD Antibodies Market Forecast 10.5.5 GCC Countries IVD Antibodies Market Forecast 10.6 Global IVD Antibodies Forecast by Type (2024-2029) 10.7 Global IVD Antibodies Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Abcam 11.1.1 Abcam Company Information 11.1.2 Abcam IVD Antibodies Product Offered 11.1.3 Abcam IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Abcam Main Business Overview 11.1.5 Abcam Latest Developments 11.2 Thermo Fisher Scientific 11.2.1 Thermo Fisher Scientific Company Information 11.2.2 Thermo Fisher Scientific IVD Antibodies Product Offered 11.2.3 Thermo Fisher Scientific IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Thermo Fisher Scientific Main Business Overview 11.2.5 Thermo Fisher Scientific Latest Developments 11.3 Rockland Immunochemicals 11.3.1 Rockland Immunochemicals Company Information 11.3.2 Rockland Immunochemicals IVD Antibodies Product Offered 11.3.3 Rockland Immunochemicals IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 Rockland Immunochemicals Main Business Overview 11.3.5 Rockland Immunochemicals Latest Developments 11.4 GenScript 11.4.1 GenScript Company Information 11.4.2 GenScript IVD Antibodies Product Offered 11.4.3 GenScript IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 GenScript Main Business Overview 11.4.5 GenScript Latest Developments 11.5 Bio-Rad Laboratories 11.5.1 Bio-Rad Laboratories Company Information 11.5.2 Bio-Rad Laboratories IVD Antibodies Product Offered 11.5.3 Bio-Rad Laboratories IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Bio-Rad Laboratories Main Business Overview 11.5.5 Bio-Rad Laboratories Latest Developments 11.6 SDIX 11.6.1 SDIX Company Information 11.6.2 SDIX IVD Antibodies Product Offered 11.6.3 SDIX IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 SDIX Main Business Overview 11.6.5 SDIX Latest Developments 11.7 MEDICAL & BIOLOGICAL LABORATORIES 11.7.1 MEDICAL & BIOLOGICAL LABORATORIES Company Information 11.7.2 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Product Offered 11.7.3 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 MEDICAL & BIOLOGICAL LABORATORIES Main Business Overview 11.7.5 MEDICAL & BIOLOGICAL LABORATORIES Latest Developments 11.8 HyTest 11.8.1 HyTest Company Information 11.8.2 HyTest IVD Antibodies Product Offered 11.8.3 HyTest IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 HyTest Main Business Overview 11.8.5 HyTest Latest Developments 11.9 Abbott 11.9.1 Abbott Company Information 11.9.2 Abbott IVD Antibodies Product Offered 11.9.3 Abbott IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 Abbott Main Business Overview 11.9.5 Abbott Latest Developments 12 Research Findings and Conclusion